Large Cap International Portfolio boosted its holdings in Smith & Nephew PLC by 226.13%, acquiring an additional 29,670 shares to bring its total to 42,791 shares. This transaction, executed during the fourth quarter of 2025, reflects the fund’s confidence in Smith & Nephew’s mid-term growth prospects. Based on the company’s latest public filings, the newly acquired position represents approximately 0.35% of the fund’s total assets under management. Institutional ownership of Smith & Nephew now stands at 62%, underscoring sustained investor interest in its global orthopaedics and wound-care divisions.

Smith & Nephew is one of 14 leading orthopaedic device manufacturers featured in the Europe Foot and Ankle Devices Market report, which projects market growth from USD 1.01 billion in 2024 to USD 1.72 billion by 2033 at a 6.1% CAGR. The company’s portfolio includes patient-specific 3D-printed implants and minimally invasive surgical systems, aligning with forecasted demand driven by an aging demographic and rising incidence of musculoskeletal disorders. In May 2024, peer firms reported over 687,700 foot and ankle events among UK children and young people, highlighting the category’s volume potential. Smith & Nephew’s ongoing collaborations with European arthroscopy training initiatives and its recent product enhancements in ankle reconstruction position it to capture a growing share of this high-growth segment.